Document Type
Article - Restricted
Publication Date
2015
Abstract
The author comments on the article "Evaluating Drug Cost per Response with SGLT2 Inhibitors in Patients with Type 2 Diabetes Mellitus" and discusses the benefits and costs of sodium-glucose cotransporter 2 inhibitors.
Recommended Citation
Nguyen, Q. T. (2015). Evaluating the benefits and cost of the sodium-glucose cotransporter 2 inhibitors. American Health & Drug Benefits, 8(6).
Publisher's Statement
Originally published in American Health & Drug Benefits, 8(6). Reprinted with permission of the publisher. Access on Touro Scholar restricted to Touro-affiliated users. This material can be found here,
